Adipocytes Protect Ovarian Cancer Cells from Ferroptosis

Ferroptosis is a regulated form of cell death driven by lipid oxidation. Induction of ferroptosis has emerged as a potential approach for cancer treatment. Work published by our group and others has suggested that ovarian cancer may be among the potential clinical targets of ferroptosis inducers. The microenvironment plays a key role in all ovarian cancers, including high-grade serous ovarian cancer (HGSOC). In particular, the adipocyte-rich omentum is an important metastatic niche for ovarian cancer peritoneal metastases. Given the pivotal role of adipocytes in the ovarian cancer microenvironment, in this work we sought to understand the contribution of adipocytes to ovarian cancer ferroptosis. We report that adipocytes and the adipocyte-conditioned medium (ACM) protect ovarian cancer cells from ferroptosis through a multifactorial process involving changes in membrane lipid composition and lipid sequestration. Inhibiting lipid transfer significantly enhanced the anti-tumor effect of erastin, a ferroptosis inducer, in immune-deficient mice bearing intraperitoneal ovarian tumors. Disabling this cytoprotective pathway may be key to the effective deployment of ferroptosis inducers in the treatment of ovarian cancer.

Authors

Institutions

Publication Details

Journal
Biomolecules
Published
2026-09-30
DOI
https://doi.org/10.3390/biom16101418
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Adipocytes Protect Ovarian Cancer Cells from Ferroptosis

Timothy E. Moore, Lia Tesfay, Kirtikar Shukla, Evan R. Jellison et al.
Biomolecules
Ferroptosis and cancer prognosis
article

Adipocytes Protect Ovarian Cancer Cells from Ferroptosis

Timothy E. Moore, Lia Tesfay, Kirtikar Shukla, Evan R. Jellison, Suzy V. Torti, Jingyun Lee, Chaeyeon Yoo, Poornima Hegde, Cristina M. Furdui
article en

Abstract

Ferroptosis is a regulated form of cell death driven by lipid oxidation. Induction of ferroptosis has emerged as a potential approach for cancer treatment. Work published by our group and others has suggested that ovarian cancer may be among the potential clinical targets of ferroptosis inducers. The microenvironment plays a key role in all ovarian cancers, including high-grade serous ovarian cancer (HGSOC). In particular, the adipocyte-rich omentum is an important metastatic niche for ovarian cancer peritoneal metastases. Given the pivotal role of adipocytes in the ovarian cancer microenvironment, in this work we sought to understand the contribution of adipocytes to ovarian cancer ferroptosis. We report that adipocytes and the adipocyte-conditioned medium (ACM) protect ovarian cancer cells from ferroptosis through a multifactorial process involving changes in membrane lipid composition and lipid sequestration. Inhibiting lipid transfer significantly enhanced the anti-tumor effect of erastin, a ferroptosis inducer, in immune-deficient mice bearing intraperitoneal ovarian tumors. Disabling this cytoprotective pathway may be key to the effective deployment of ferroptosis inducers in the treatment of ovarian cancer.

BiomoleculesVol. 16(10)
University of Connecticut (US), Statistical Research (United States) (US), Wake Forest University Health Sciences (US), Wake Forest University (US), UConn Health (US)
Good health and well-being
Openalex Percentile: Top 12%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adipocytes Protect Ovarian Cancer Cells from Ferroptosis — Timothy E. Moore, Lia Tesfay, et al. · Biomolecules (2026) | TGRS Research Map | TGRS